Table of Contents
ISRN Pharmaceutics
Volume 2013, Article ID 348186, 10 pages
http://dx.doi.org/10.1155/2013/348186
Review Article

Pharmacosomes: An Emerging Novel Vesicular Drug Delivery System for Poorly Soluble Synthetic and Herbal Drugs

Nanomedical Research Centre, I.S.F. College of Pharmacy, Ferozepur G.T. Road Ghal Kalan, Moga, Punjab 142001, India

Received 2 July 2013; Accepted 1 August 2013

Academic Editors: F.-R. Chang, J. V. de Julián-Ortiz, J. Lee, and H. Mucke

Copyright © 2013 Archana Pandita and Pooja Sharma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Patel and P. D. Bharadia, “A review on: pharamacosomes as a novel vesicular drug delivery system,” WJPR, vol. 1, pp. 456–469, 2012. View at Google Scholar
  2. K. De Pintu and De Arnab, “Pharmacosomes: a potential drug delivery system,” International Research Journal of Pharmacy, vol. 3, pp. 102–105, 2012. View at Google Scholar
  3. S. Saraf, R. Rathi, C. D. Kaur, and S. Saraf, “Colloidosomes an advanced vesicular system in drug delivery,” Asian Journal of Scientific Research, vol. 4, no. 1, pp. 1–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Deepti, R. Madhukar, R. Jukanti, B. Suresh, P. Reddy, and V. Reddy, “Provesicular drug delivery systems: an overview and appraisal,” Scholars Research Library, vol. 2, no. 4, pp. 135–146, 2010. View at Google Scholar
  5. R. K. Kesarvani, A. K. Sharma, M. D. Ayaz, and R. K. Kesharwani, “Review novel drug delivery system for the vesicular delivery of drug by the niosomes,” International Journal of Research in Controlled Release, vol. 1, pp. 1–8, 2011. View at Google Scholar
  6. S. Gupta, R. P. Singh, P. Lokwani, S. Yadav, and S. K. Gupta, “Vesicular system as targeted drug delivery system: an overview,” International Journal of Pharmacy and Technology, vol. 3, no. 2, pp. 987–1021, 2011. View at Google Scholar · View at Scopus
  7. R. C. Doijad, D. S. Bhambere, M. V. Fakirappa, and N. V. Deshmukh, “Formulation and characterization of vesicular drug delivery system for anti-HIV drug,” Journal of Global Pharma Technology, vol. 1, no. 1, pp. 94–100, 2009. View at Google Scholar
  8. M. J. Pozansky and R. L. Juliano, “Biological approaches to the controlled delivery of drugs: a critical review,” Pharmacological Reviews, vol. 36, no. 4, pp. 277–336, 1983. View at Google Scholar
  9. A. D. Bangham, M. M. Standish, and G. Weissmann, “The action of steroids and streptolysin S on the permeability of phospholipid structures to cations,” Journal of Molecular Biology, vol. 13, no. 1, pp. 253–259, 1965. View at Google Scholar · View at Scopus
  10. U. Ogihara, T. Sasaki, H. Toyama, O. M. Sneha, and H. Nishigori, “Rapid diagnostic imaging of cancer using radiolabeled liposomes,” Cancer Detection and Prevention Journal, vol. 21, pp. 490–496, 1997. View at Google Scholar
  11. D. Kavitha, J. Naga Sowjanya, and S. Panaganti, “Pharmacosomes: an emerging vesicular system,” International Journal of Pharmaceutical Sciences Review and Research, vol. 5, no. 3, pp. 168–171, 2010. View at Google Scholar · View at Scopus
  12. S. Biju, S. Talegaonkar, P. Mishra, and R. Khar, “Vesicular systems: an overview,” Indian Journal of Pharmaceutical Sciences, vol. 71, pp. 421–427, 2009. View at Google Scholar · View at Scopus
  13. M. P. Wagh and J. S. Patel, “Biopharmaceutical classification system: scientific basis for biowaiver extensions,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 2, no. 1, pp. 12–19, 2010. View at Google Scholar · View at Scopus
  14. R. Löbenberg and G. L. Amidon, “Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 3–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Varshosaz, R. Talari, S. A. Mostafavi, and A. Nokhodchi, “Dissolution enhancement of gliclazide using in situ micronization by solvent change method,” Powder Technology, vol. 187, no. 3, pp. 222–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. V. E. Ivanov, Y. S. Moshkovskii, and L. M. Raikhman, “Effects of temperature on cascade systems of pharmacosome fusion,” Pharmaceutical Chemistry Journal, vol. 15, no. 9, pp. 619–621, 1981. View at Publisher · View at Google Scholar · View at Scopus
  17. M. K. Rawat, A. Jain, and S. Singh, “In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats,” Journal of Pharmaceutical Sciences, vol. 100, no. 6, pp. 2406–2417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. K. Jain, Advances in Controlled and Novel Drug Delivery, CBS, 2003.
  19. S. Sharma, L. Mishra, I. Grover, A. Gupta, and K. Kaur, “Liposomes: vesicular system an overview,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 2, no. 4, pp. 15–21, 2010. View at Google Scholar
  20. A. Semalty, M. Semalty, B. S. Rawat, D. Singh, and M. S. M. Rawat, “Pharmacosomes: the lipid-based new drug delivery system,” Expert Opinion on Drug Delivery, vol. 6, no. 6, pp. 599–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Semalty, M. Semalty, B. S. Rawat, D. Singh, and M. S. M. Rawat, “Development and evaluation of pharmacosomes of aceclofenac,” Indian Journal of Pharmaceutical Sciences, vol. 72, no. 5, pp. 576–581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Steve, “Lipophilic drug derivatives for use in liposomes,” US Patent S, 534, 499, (C1 S14-25, A61K31/70), 1996.
  23. I. Taskintuna, A. S. Banker, M. Flores-Aguilar et al., “Evaluation of a novel lipid prodrug for intraocular drug delivery: effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis,” Retina, vol. 17, no. 1, pp. 57–64, 1997. View at Google Scholar · View at Scopus
  24. F. Franceschi and A. Giori, A Phospholipid Complex of Olive Fruits or Leaves Extracts Having Improved Bioavailability, EP1844785, 2007.
  25. F. Di Pierro, Compositions Comprising Gingko Biloba Derivatives for the Treatment of Asthmatic and Allergic Conditions, EP1813280, 2007.
  26. T. Doering, A. Traeger, and M. Waldmann-Laue, Cosmetic and Dermatological Composition For the Treatment of Aging or Photodamaged Skin, EP1640041, 2006.
  27. E. Bombardelli, G. F. Patri, and R. Pozzi, Complexes of Saponins With Phospholipids and Pharmaceutical and Cosmetic Compositions Containing Them, EP0283713, 1988.
  28. H. K. Kleinman and A. L. Goldstein, Treatment of skin, and wound repair, with thymosin beta-4, U.S Patent No- 20070015698, 2007.
  29. H. K. Kleinman and A. L. Goldstein, Treatment of skin, and wound repair, with thymosin beta 4, U.S.PatentNo-20070015698, 2007, Khare A B, Soluble isoflavone compositions, WO/2004/ 045541, 2004.
  30. G. Merizzi, An Anti-Oxidant Preparation Based on Plant Extracts for the Treatment of Circulation and Adiposity Problems, EP1214084, 2002.
  31. M. O. Vaizoglu and P. P. Speiser, “Pharmacosomes—a novel drug delivery system,” Acta Pharmaceutica Suecica, vol. 23, no. 3, pp. 163–172, 1986. View at Google Scholar · View at Scopus
  32. I. P. Kaur and M. Kanwar, “Ocular preparations: the formulation approach,” Drug Development and Industrial Pharmacy, vol. 28, no. 5, pp. 473–493, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Semalty, M. Semalty, D. Singh, and M. S. M. Rawat, “Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery,” Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol. 67, no. 3, pp. 253–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Lawrence, “Surfactant systems: their use in drug delivery,” Chemical Society Reviews, vol. 23, no. 6, pp. 417–424, 1994. View at Google Scholar · View at Scopus
  35. C. C. Muller-Goymann and H.-J. Hamann, “Pharmacosomes—multilamellar vesicles consisting of pure drug,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 37, no. 2, pp. 113–117, 1991. View at Google Scholar · View at Scopus
  36. J. S. Valentino and N. C. William, Lymphatic Transport of Drugs, CRC Press, Boca Raton, Fla, USA, 1992.
  37. A. Singh and R. Jain, “Targeted Vesicular Constructs for cryoprotection and treatment of H.Pylori infections,” US Patent 6576, 625, 2003.
  38. Y. Li, D. J. Yang, S. L. Chen, S. B. Chen, and A. S. C. Chan, “Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods,” Pharmaceutical Research, vol. 25, no. 3, pp. 563–577, 2008. View at Publisher · View at Google Scholar
  39. E. Bombardelli and M. Spelta, “Phospholipid-polyphenol complexes: a new concept in skin care ingredients,” Cosmetics & Toiletries, vol. 106, pp. 69–76, 1991. View at Google Scholar
  40. E. P. Goldberg, Targeted Drugs, Wiley Newyork, 1983.
  41. A. Ping, Y. Jin, and C. Da-wei, “Preparation and in vivo behaviour of didanosinepharmacosomes in rats,” Journal of Chinese Pharmaceutical, vol. 3, pp. 227–235, 2005. View at Google Scholar
  42. S. K. P. Rajapati, S. Kumar, V. K. Sahu, and G. Prakash, “Proniosomal gel of flurbiprofen: formulation and evaluation,” Journal of Drug Delivery and Therapeutics, vol. 2, no. 1, pp. 105–114, 2012. View at Google Scholar
  43. S. P. Vyas, V. Jaitely, and P. Kanaujia, “Synthesis and characterisation of palymitoyl propanolol hydrochloride auto-lymphotrophs for oral administration,” International Journal of Pharmaceutics, vol. 186, no. 2, pp. 177–189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. P.-F. Yue, Q. Zheng, B. Wu et al., “Process optimization by response surface design and characterization study on geniposide pharmacosomes,” Pharmaceutical Development and Technology, vol. 17, no. 1, pp. 94–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. B. Khare, “Soluble isoflavone compositions,” WO/2004/045541, 2004.
  46. H. A. Lieberman, M. M. Rieger, and G. S. S. Banker, Pharmaceutical Dosage Forms: Disperse Systems, Informa Healthcare, London, UK, 1998.
  47. B. M. Mithal, Ocular Dosage Forms, Text Book of Pharmaceutical Formulations, VallabhPrakashan, New Delhi, India, 1997.
  48. F. La Torre and A. P. Nicolal, “Amikacin gel administration in the treatment of peristomal dermatitis,” Drugs under experimental and clinical research, vol. 24, no. 3, pp. 153–157, 1998. View at Google Scholar
  49. L. M. Raikhman, Y. S. Moshkovskii, and L. A. Piruzyan, “Pharmacosome concept: a new approach to drug preparation,” Pharmaceutical Chemistry Journal, vol. 12, no. 4, pp. 431–434, 1978. View at Google Scholar
  50. A. Semalty, M. Semalty, D. Singh, and M. S. M. Rawat, “Development and physicochemical evaluation of pharmacosomes of diclofenac,” Acta Pharmaceutica, vol. 59, no. 3, pp. 335–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Han, J. Chen, S. Chen, and X. Wang, “Preparation and study in vitro of 20(S) protopanaxadiolpharmacosomes,” China Journal of Pharmaceutics, vol. 35, pp. 842–846, 2010. View at Google Scholar
  52. Z.-R. Zhang, J.-X. Wang, and J. Lu, “Optimization of the preparation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine pharmacosomes using central composite design,” Yaoxue Xuebao, vol. 36, no. 6, pp. 456–461, 2001. View at Google Scholar · View at Scopus
  53. J. Yi-Guang, A. I. Ping, L. I. Miao, and H. Xin-Pu, “Preparation and properties of Acyclovir pharmacosomes,” Chinese Journal of Pharmaceuticals, vol. 36, no. 10, pp. 617–620, 2005. View at Google Scholar
  54. S. Shalini and R. K. Roy, “Phytosomes: an emerging technology,” International Journal of Pharmaceutical Research and Development, vol. 2, pp. 14–15, 2010. View at Google Scholar
  55. P. Shivanand and P. Kinjal, “Phytosomes: technical revolution in phytomedicine,” International Journal of PharmTech Research, vol. 2, no. 1, pp. 627–631, 2010. View at Google Scholar · View at Scopus
  56. E. Bombardelli and G. Mustich, “bilobalidephosphalipid complex, their uses and formulation containing them,” U.S. Patent No. EPO-275005 ,1991.
  57. D. Murray, “Phytosomes-increase the absorption herbal extract,” http://doctormurray.com/phytosomes-herbal-support-increase-the-absorption-of-herbal-extracts/.
  58. C. Marena and M. Lampertico, “Preliminary clinical development of silipide: a new complex of silybin in toxic liver disorders,” Planta Medica, vol. 57, no. 2, pp. A124–A125, 1991. View at Google Scholar · View at Scopus
  59. N. S. Chauhan, R. Gowtham, and B. Gopalkrishna, “Phytosomes: a potential Phytophospholipid carriers for herbal drug delivery,” Journal of Pharmacy Research, vol. 2, pp. 1267–1270, 2009. View at Google Scholar
  60. N. K. Jain, Controlled and Novel Drug Delivery, CBS, New York, NY, USA, 1st edition, 2005.
  61. A. Semalty, M. Semalty, and M. S. Rawat, “The Phytophospholipid complexes phytosomes: a potential therapeutic approach for hepatoprotective drug delivery,” Pharmacognosy Review, vol. 1, no. 2, pp. 369–374, 2007. View at Google Scholar
  62. A. D. Kingom, “Pharmacognosy in 21 st century,” The Journal of Pharmacy and Pharmacology, vol. 53, no. 2, pp. 135–148, 2001. View at Google Scholar
  63. B. Gabetta, E. Bombardelli, and G. Pifferi, “Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions,” U. S. Patent no-4764508, 1986.
  64. E. Bombardelli, M. Spelta, R. Della Loggia, S. Sosa, and A. Tubaro, “Aging skin: protective effect of Silymarin-phytosome,” Fitoterapia, vol. 62, no. 2, pp. 115–122, 1991. View at Google Scholar · View at Scopus
  65. E. Bombardelli, A. Cristoni, and P. Morazzoni, “Phytosomes in functional cosmetics,” Fitoterapia, vol. 65, no. 5, pp. 387–401, 1994. View at Google Scholar · View at Scopus
  66. S. Sharma and M. Sikarwar, “Phytosome: a review,” Plant Indica, vol. 1, pp. 1–3, 2005. View at Google Scholar
  67. S. Bhattacharya, “Phytosomes: emerging strategy in delivery of herbal drugs and nutraceuticals,” Pharma Times, vol. 41, no. 3, pp. 9–12, 2009. View at Google Scholar · View at Scopus
  68. S. Bhattacharya, “Phytosomes: the new technology for enhancement of bioavailability of botanicals and nutraceuticals,” International Journal of Health Research, vol. 2, no. 3, pp. 225–232, 2009. View at Google Scholar · View at Scopus
  69. P. M. Kidd, PHYTOSOMES, Highly Bioavailable Plant Extracts, http://www.dockidd.com/pdf/2LinksPhytosomeInd,5_10_04.pdf.
  70. A. Joshi, S. Chaturvedi, and V. Kumar, Phytosomes-A Revolution in Herbal Drugs, Pharma Review, Kongposh publications, 2008.